| abstract |
The invention relates to a compound of the formula (I) wherein m is 1-2 and each R1 is a group such as cyano, halogen, trifluoromethyl and heterocyclyloxy; R2 is trifluoromethyl or C1-C6 alkyl; R3 is hydrogen or halogen and R4 is isoxazolyl, or pharmaceutically acceptable salts thereof; to procedures for its preparation, to pharmaceutical compositions containing it and to its use in the treatment of diseases or medical conditions mediated by cytokines. |